CRIS Current Research Information System

RIMONDINI GIORGINI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.533
EU - Europa 4.409
AS - Asia 4.150
AF - Africa 318
SA - Sud America 257
OC - Oceania 13
Totale 14.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.479
IT - Italia 1.480
SG - Singapore 1.461
CN - Cina 1.197
GB - Regno Unito 900
VN - Vietnam 595
DE - Germania 592
HK - Hong Kong 330
IN - India 282
SE - Svezia 270
RU - Federazione Russa 202
BR - Brasile 183
NL - Olanda 167
UA - Ucraina 164
FR - Francia 156
IE - Irlanda 152
TG - Togo 99
KR - Corea 79
ZA - Sudafrica 78
JP - Giappone 66
CI - Costa d'Avorio 64
EE - Estonia 54
BG - Bulgaria 48
FI - Finlandia 45
SC - Seychelles 44
ID - Indonesia 37
AR - Argentina 33
ES - Italia 33
CA - Canada 32
JO - Giordania 26
BE - Belgio 25
CH - Svizzera 22
AT - Austria 21
NG - Nigeria 19
MX - Messico 17
PL - Polonia 17
HR - Croazia 15
AU - Australia 11
TR - Turchia 11
CO - Colombia 10
EC - Ecuador 10
BD - Bangladesh 9
GR - Grecia 9
LT - Lituania 9
CL - Cile 8
PH - Filippine 8
MA - Marocco 7
MY - Malesia 7
IR - Iran 6
PT - Portogallo 5
SM - San Marino 5
AL - Albania 4
IQ - Iraq 4
PE - Perù 4
PY - Paraguay 4
IL - Israele 3
NP - Nepal 3
SA - Arabia Saudita 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
RO - Romania 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
BH - Bahrain 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GL - Groenlandia 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 14.680
Salva come PNG Salva come JPEG
Città #
Singapore 1.011
Southend 790
Fairfield 526
Ashburn 519
Chandler 472
Bologna 443
Hong Kong 313
Santa Clara 297
Woodbridge 249
Wilmington 246
Princeton 237
Houston 219
Seattle 212
Cambridge 201
Hefei 188
Dong Ket 167
Ann Arbor 164
Beijing 158
Dublin 150
New York 149
Dallas 148
Boardman 142
Jacksonville 104
Los Angeles 100
Lomé 99
Ho Chi Minh City 98
Milan 88
Berlin 85
Nanjing 74
Seoul 74
Westminster 70
Hanoi 68
Abidjan 64
Buffalo 64
Padova 63
Tokyo 59
Jinan 55
Turin 53
San Diego 49
Sofia 48
Rome 47
Des Moines 37
Trento 36
Modena 35
Helsinki 34
Redmond 34
Redondo Beach 34
Falls Church 32
Shanghai 32
Saint Petersburg 29
Tianjin 29
Shenyang 28
São Paulo 28
Amman 26
Frankfurt am Main 26
Jakarta 26
Changsha 25
Medford 25
Mülheim 24
Brussels 23
Verona 23
Nanchang 22
Chicago 21
Guangzhou 21
Jiaxing 21
Munich 21
Hebei 20
Naples 20
Pune 19
Florence 18
Bengaluru 16
Marano 16
Bern 15
Mordano 15
Phoenix 14
Abeokuta 13
Argelato 13
Hangzhou 13
Redwood City 13
Toronto 13
Warsaw 13
Bolzano 12
Falkenstein 12
Haikou 12
Jerez De La Frontera 12
London 12
Norwalk 12
San Venanzo 12
Wuhan 12
Yubileyny 12
Zhengzhou 12
Brooklyn 11
Dearborn 11
San Francisco 11
Amsterdam 10
Bari 10
Bristol 10
Castel Maggiore 10
Da Nang 10
Fuzhou 10
Totale 9.499
Salva come PNG Salva come JPEG
Nome #
Lezioni di Farmacologia Generale 345
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 294
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 290
A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS 258
Altered globotriaosylceramide accumulation and mucosal neuronal fiber density in the colon of the Fabry disease mouse model 253
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 228
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 227
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 214
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 209
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 202
Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse 192
Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways 189
Bando Progetti di Ricerca Giovani Ricercatori – Ricerca Finalizzata 2010 Project Title:Biomolecular and functional analysis of pathogenetic mechanisms of neuropathic pain in genetic and acquired small fibre neuropathies. Project Code:RF-2010-2313899 188
Neuroscienze 187
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 187
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 185
Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model 184
An ionotropic but not a metabotropic glutamate agonist potentiates the pharmacological effects of olanzapine in the rat 180
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 177
Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice 176
CNF1 Increases Brain Energy Level, Counteracts Neuroinflammatory Markers and Rescues Cognitive Deficits in a Murine Model of Alzheimer's Disease 175
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 172
Antimicrobial effect of MTAD, Tetraclean, Cloreximid, and sodium hypochlorite on three common endodontic pathogens. 171
The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy 171
Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease 167
Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease 166
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 166
Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis 161
The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability. 158
Cross-disease analysis of Alzheimer’s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases 152
Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain. 152
Chronic alcohol abuse and endosseous implants: Linkage of in vitro osteoblast dysfunction to titanium osseointegration rate. 149
Excitotoxic lesion of the perirhinal cortex impairs spatial working memory in a delayed-alternation task. 149
Combination of Apolipoprotein E4 and High Carbohydrate Diet Reduces Hippocampal BDNF and Arc Levels and Impairs Memory in Young Mice. 145
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 144
Pain Related Channels Are Differentially Expressed in Neuronal and Non-Neuronal Cells of Glabrous Skin of Fabry Knockout Male Mice 144
Olanzapine counteracts stress-induced anxiety-like behavior in rats 143
C57BL/6J and DBA/2J strains present opposite sex differences in flash visual evoked potential latency: A possible confusing factor in gender studies on neurological diseases’ transgenic models 143
Induction of a high alcohol consumption in rats and mice: Role of opioid receptors in rats and mice 142
Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: Evidence for an allostatic shift? 139
Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence 139
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 139
MicroRNAs Associated with IgLON Cell Adhesion Molecule Expression 134
L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors 132
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 130
Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence. 130
Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats. 130
null 130
Long-term suppression of forebrain neurogenesis and loss of neuronal progenitor cells following prolonged alcohol dependence in rats. 129
Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice 128
Use of CNF1 to treat neuroinflammation and astrogliosis in CNS diseases 128
Mechanical Nociception Measurement in Mice and Rats with Automated Von Frey Equipment 126
Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior. 125
Mechanical nociception in mice and rats: Measurement with automated von frey equipment 123
Induction of a High Alcohol Consumption in Rats and Mice: Role of Opioid ReceptorsOpioid Receptors 122
Chromatographic analysis of atypical antipsychotic olanzapine and its main metabolite in rat plasma and brain samples after chronic administration. 121
Water T-maze, an improved method to assess spatial working memory in rats: Pharmacological validation. 121
The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases 120
In vitro effects of a chemically modified titanium surface on ethanol-exposed osteoblasts. 120
A role for beta-arrestin 2 in mediating the rewarding properties of ethanol 119
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 117
Early post-natal life stress induces permanent adrenocorticotropin-dependent hypercortisolism in male mice 117
Acute ethanol challenge inhibits glycogen synthase kinase-3beta in the rat prefrontal cortex. 116
Upregulation of Voluntary Alcohol Intake, Behavioral Sensitivity to Stress, and Amygdala Crhr1 Expression Following a History of Dependence. 115
Impaired plasma membrane calcium ATPase activity and mitochondrial dysfunction contribute to calcium dysregulation in Fabry disease-related painful neuropathy 114
Long-lasting tolerance to alcohol following a history of dependence. 114
Neuroplasticity in brain reward circuitry following a history of ethanol dependence. 113
Alcohol exposures induce selective alterations on endogenous opioid system genes regulation in rat amygdala: possible epigenetic mechanisms 112
Intermittent exposure to ethanol vapor affects osteoblast behaviour more severely than estrogen deficiency does in vitro study on rat osteoblasts. 107
Modulation of voluntary ethanol consumption by beta-arrestin 2. 104
Comparative evaluation of antimicrobial efficacy of sodium hypochlorite, MTAD,and Tetraclean against Enterococcus faecalis biofilm. 103
Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. 101
Age-related alteration of the adenosine/dopamine balance in the rat striatum 100
null 97
c-fos antisense oligonucleotides increase firing rate of striatal neurons in the anaesthetized rat 95
Buprenorphine Reduces Alcohol Drinking Through Activation of the Nociceptin/Orphanin FQ-NOP Receptor System. 95
D-Cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain 95
PLASTICITY AND IMPACT OF THE CENTRAL RENIN-ANGIOTENSIN SYSTEM DURING DEVELOPMENT OF ETHANOL DEPENDENCE 94
'Atypical' neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: In vitro and in vivo studies 92
The NMDA positive modulator d-cycloserine inhibits dopamine-mediated behaviors in the rat 91
Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention 90
CRH signaling and the dark side of addiction: Long-lasting hyper-reactivity to stress in animals with a history of ethanol dependence 89
CRH SIGNALING AND THE DARK SIDE OF ADDICTION: LONG LASTING HYPERREACTIVITY TO STRESS IN ANIMALS WITH A HISTORY OF ALCOHOL DEPENDENCE 89
Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum 88
Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. 87
Modulation of voluntary ethanol consumption by beta-arrestin 2 86
RECRUITMENT OF INHIBITORY MEK/ERK SIGNALING IN BRAIN REWARD CIRCUITRY FOLLOWING A HISTORY OF ETHANOL DEPENDENCE 85
Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine 85
Repeated administrations of (-)-deprenyl increase [3H]MK801 binding in rat brain and antagonize the impairment of passive avoidance conditioning induced by N-methyl-d-aspartate receptor antagonists 84
Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats 84
Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance 83
Adenosine A2A agonists: A potential new type of atypical antipsychotic 81
LONG-LASTING SUPPRESSION OF SUBVENTRICULAR ZONE NEUROGENESIS FOLLOWING A HISTORY OF ETHANOL DEPENDENCE 80
The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function 79
The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms 79
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. 78
New therapeutic strategies for Alzheimer's disease: induction of neural plasticity and mitochondria bolstering by the Rho GTPases' activator CNF1 76
Adenosine A(2A) and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum 75
Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats 73
Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test 72
Totale 13.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021825 0 0 0 0 0 57 13 86 98 69 72 430
2021/20222.184 196 76 206 114 216 143 73 184 86 167 370 353
2022/20232.198 206 357 136 236 170 185 67 133 333 65 202 108
2023/2024850 27 95 62 81 62 252 46 51 23 76 41 34
2024/20252.872 138 444 330 263 446 144 226 86 79 191 111 414
2025/20263.049 403 594 624 433 840 155 0 0 0 0 0 0
Totale 15.110